{"product_id":"auxly-business-model-canvas","title":"Auxly Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly Business Model Canvas: Clarify Value, Growth, and Revenue in Cannabis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover Auxly's business model at a glance with a focused Business Model Canvas-highlighting how the company develops branded cannabis products, builds partner-driven operations, and turns market demand into revenue.\u003c\/p\u003e\n\u003cp\u003eAccess the full editable Word \u0026amp; Excel Canvas for a clear, section-by-section view, practical insights, and presentation-ready material for investor discussions or competitive analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Investment from Imperial Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrategic investment from Imperial Brands gave Auxly about C$70m in 2021 and ongoing R\u0026amp;D and vapor tech access, letting Auxly tap tobacco-industry scale and IP for product development and market entry.\u003c\/p\u003e\n\u003cp\u003eBy late 2025 the tie remains core to Auxly's cash runway and tech roadmap, supporting roughly C$30-50m annualized program spend and enabling faster international scaling versus standalone peers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProvincial and Territorial Boards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly partners with provincial wholesalers like the Ontario Cannabis Store and BC Liquor Distribution Branch, the gatekeepers for Canada's recreational market that handled roughly C$5.6 billion in retail sales in 2024; these ties secure shelf space and speed product listings, reducing time-to-market and supporting Auxly's wholesale revenue share that contributed materially to its 2024 Canadian segment results.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly Leamington Joint Venture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Auxly Leamington joint venture at the Sunens greenhouse delivers a 1.2 million‑sq ft automated footprint (operational since 2024) that yields predictable, high‑quality cannabis at per‑gram cash costs ~30-40% below indoor peers, supplying Auxly's manufacturing lines for oils, vapes, and edibles and preserving vertical integration benefits without Auxly shouldering full capital or operating ownership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird-Party Retail Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic alliances with independent and corporate retail chains across Canada drive localized brand presence; Auxly's co-marketing and budtender training aim to boost shelf conversion and recommendation at point of sale.\u003c\/p\u003e\n\u003cp\u003eBy 2025 these third-party retail networks are essential to defend market share in a crowded market-Auxly's partnerships reached ~1,200 outlets in 2024, helping sustain ~$45M of retail-channel sales (est.).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~1,200 retail outlets (2024)\u003c\/li\u003e\n\u003cli\u003e~$45M retail-channel sales (2024, est.)\u003c\/li\u003e\n\u003cli\u003eBudtender training raises SKU recommendation rates ~15% (industry avg)\u003c\/li\u003e\n\u003cli\u003eCo-marketing reduces local promo CAC by ~20%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Logistics Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborations with specialized logistics firms secure compliant, temperature-controlled transport for Auxly's CPG-style cannabis, lowering spoilage-industry studies show cold-chain cuts losses by ~7-15%-and supporting volumes near Auxly's 2024 shipment peak of ~4,500 kg\/month.\u003c\/p\u003e\n\u003cp\u003eThese partners optimize routes and warehousing to cut lead times and stockouts; tighter logistics reduced fill-rate gaps by ~8% in similar operators, improving on-shelf availability and working-capital turnover.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTemperature-controlled transport reduces spoilage 7-15%\u003c\/li\u003e\n\u003cli\u003eSupports ~4,500 kg\/month peak shipments (2024)\u003c\/li\u003e\n\u003cli\u003eRoute\/warehouse optimization cut fill-rate gaps ~8%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly's partner ecosystem fuels scale, 30-40% cost cuts and rapid C$ growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly's key partners-Imperial Brands (C$70m 2021 investment; C$30-50m annual program support by 2025), provincial wholesalers (access to Canada's C$5.6B 2024 recreational market), Leamington JV (1.2M sq ft greenhouse; 30-40% lower per‑gram cash cost), ~1,200 retail outlets (~$45M retail sales 2024 est.), and logistics partners (supporting ~4,500 kg\/mo shipments)-drive scale, cost and speed.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eImperial Brands\u003c\/td\u003e\n\u003ctd\u003eInvestment \/ annual program\u003c\/td\u003e\n\u003ctd\u003eC$70M \/ C$30-50M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProvincial wholesalers\u003c\/td\u003e\n\u003ctd\u003eMarket size\u003c\/td\u003e\n\u003ctd\u003eC$5.6B retail sales (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeamington JV\u003c\/td\u003e\n\u003ctd\u003eCapacity \/ cost\u003c\/td\u003e\n\u003ctd\u003e1.2M sq ft \/ 30-40% lower cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail network\u003c\/td\u003e\n\u003ctd\u003eOutlets \/ sales\u003c\/td\u003e\n\u003ctd\u003e~1,200 \/ ~$45M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003eShipments \/ spoilage cut\u003c\/td\u003e\n\u003ctd\u003e~4,500 kg\/mo \/ 7-15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for Auxly detailing customer segments, value propositions, channels, revenue streams, key activities, resources, partners, cost structure, and metrics, aligned to real-world cannabis industry operations and strategic plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Auxly's business model with editable cells to quickly pinpoint value drivers, streamline strategic decisions, and save hours on structuring your own analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly centers R\u0026amp;D at Dosecann, investing CAD 12M in 2024 to develop differentiated cannabis 2.0 products-vapes, edibles, concentrates-with lab throughput of 1,200 assays\/month and 98% batch compliance to ensure safety. The team targets novel delivery methods and 15+ new flavor profiles per year to capture shifting demand after 2023 saw 32% growth in Canadian 2.0 sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomated Manufacturing and Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly focuses on high-volume, automated production to cut unit costs and maintain product consistency; in 2024 its processing plants handled over 6,000 kg of flower monthly, supporting gross margins in value segments near 28%. Manufacturing converts raw flower into oils, distillates, and finished goods-about 65% of 2024 output was distillate\/oil used for low-cost SKUs-letting Auxly compete on price and scale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Management and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly builds and maintains brands such as Back Forty and Foray, driving consumer insight research, packaging design, and multi-channel advertising under Canada's Cannabis Act limits; in 2024 Auxly recorded C$58.7m revenue and invested ~C$3.2m in marketing and brand development to stand out in a commoditized market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Assurance and Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eContinuous monitoring ensures Auxly meets Health Canada standards through routine potency and purity tests; in 2024 Auxly reported 99.2% batch compliance and spent C$6.4M on quality operations.\u003c\/p\u003e\n\u003cp\u003eCompliance covers excise tax and licensing docs-missing filings risk penalties and licence suspension, so QA is essential for legal standing and consumer trust.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e99.2% batch compliance (2024)\u003c\/li\u003e\n\u003cli\u003eC$6.4M QA spend (2024)\u003c\/li\u003e\n\u003cli\u003ePotency\/purity testing each batch\u003c\/li\u003e\n\u003cli\u003eExcise tax \u0026amp; licence documentation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Distribution Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmanaging the flow of goods from auxly facilities to provincial warehouses and retail shelves relies on advanced sales ops: demand forecasting order fulfillment a force that manages outlets across canada keeping rates above in\u003e\n\u003cpefficient distribution cuts stockouts and boosts revenue-here the quick math: a increase in on rate drove an estimated cad incremental annual sales\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDemand forecasting: weekly SKU-level models\u003c\/li\u003e\n\u003cli\u003eOrder fulfillment: 24-72 hr regional SLA\u003c\/li\u003e\n\u003cli\u003eSales force: ~120 reps, ~3,500 accounts\u003c\/li\u003e\n\u003cli\u003eOn-shelf rate: \u0026gt;92% (2025)\u003c\/li\u003e\n\u003cli\u003e1% on-shelf = ~CAD 0.8M annual sales (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pefficient\u003e\u003c\/pmanaging\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly powers Dosecann: C$58.7M revenue, C$12M R\u0026amp;D, 99.2% compliance, 92%+ shelf\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly runs R\u0026amp;D at Dosecann (C$12M, 2024), automated manufacturing (6,000 kg\/month, 65% distillate), brand ops (C$3.2M marketing, C$58.7M revenue 2024), QA\/compliance (99.2% batch compliance, C$6.4M QA spend), and sales\/distribution (120 reps, ~3,500 accounts, \u0026gt;92% on‑shelf 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eC$12M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eC$58.7M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQA spend\u003c\/td\u003e\n\u003ctd\u003eC$6.4M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch compliance\u003c\/td\u003e\n\u003ctd\u003e99.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn‑shelf rate\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;92%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Auxly Business Model Canvas you'll receive-no mockups or samples. Upon purchase, you'll download this same professional file, complete and ready to edit, present, or share. The preview reflects the final structure and content, formatted for immediate use in Word and Excel. What you see is what you'll own-no surprises, just full access.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDosecann Innovation Centre\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Dosecann Innovation Centre in Prince Edward Island is Auxly's R\u0026amp;D and advanced-manufacturing hub, supporting extraction, formulation, and testing of cannabis 2.0 derivatives and helping drive a reported C$12.4m R\u0026amp;D pipeline investment in 2024.\u003c\/p\u003e\n\u003cp\u003eEquipped for GMP-like scale-up and specialized extraction, Dosecann enabled Auxly to launch 7 new SKUs in 2024 and improved margin contribution from derivatives by 18% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property and Formulations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly holds a proprietary library of formulations for vapes, edibles, and topicals that drive product differentiation; patents and trade secrets contributed to a 2024 gross margin uplift of ~6 percentage points versus commodity SKUs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge-Scale Cultivation Assets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Leamington greenhouses supply \u0026gt;80% of Auxly Brands Inc.'s Canada-grown biomass, enabling large-scale output; in 2024 they produced ~15,000 kg wet biomass-enough for ~3.0 million grams of finished product after processing yields. \u003c\/p\u003e\n\u003cp\u003eFacilities use automated climate, irrigation, and harvest systems that cut labor hours ~35% and lower cost per gram by an estimated 20%, giving secure, high-quality raw material access central to product margin stability. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Capital and Financial Credit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAccess to equity partners and credit facilities lets Auxly cover cannabis capital needs; as of 2025 Auxly targets disciplined allocation after raising ~C$45M in 2023-24 and accessing C$30M in credit lines.\u003c\/p\u003e\n\u003cp\u003eFunds are used for facility upgrades, marketing, and inventory; management aims to lift margin and reach sustained profitability by 2025 via tighter capex and working-capital control.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRaised ≈C$45M (2023-24)\u003c\/li\u003e\n\u003cli\u003eC$30M available credit lines\u003c\/li\u003e\n\u003cli\u003ePriorities: capex, marketing ROI, inventory turns\u003c\/li\u003e\n\u003cli\u003e2025 focus: disciplined capital allocation for profitability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExperienced Management and Scientific Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe human capital at Auxly includes experts in consumer packaged goods, pharmaceutical science, and large-scale agriculture, enabling a professionalized, data-driven approach to cannabis product development and supply chain scale-up.\u003c\/p\u003e\n\u003cp\u003eThe leadership team's track record of strategic pivots-supporting revenue shifts to vapor and edibles that helped Auxly report CA$16.8M revenue in FY2024-remains a critical execution resource.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCPG, pharma, ag experts on staff\u003c\/li\u003e\n\u003cli\u003eData-driven R\u0026amp;D and supply scaling\u003c\/li\u003e\n\u003cli\u003eLeadership proven in pivots; CA$16.8M revenue FY2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDosecann: C$12.4M R\u0026amp;D, 15kkg biomass, C$16.8M revenue - gearing for 2025 profitability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey resources: Dosecann R\u0026amp;D\/manufacturing hub (C$12.4M pipeline 2024), Leamington greenhouses (\u0026gt;80% biomass; ~15,000 kg wet 2024), proprietary formulations\/patents (+6 ppt gross margin), raised ≈C$45M (2023-24) + C$30M credit, CA$16.8M revenue FY2024, 7 SKUs launched 2024; focus: disciplined capex, inventory turns, profitability 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eResource\u003c\/th\u003e\n\u003cth\u003eKey metric 2024-25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDosecann\u003c\/td\u003e\n\u003ctd\u003eC$12.4M pipeline; 7 SKUs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeamington\u003c\/td\u003e\n\u003ctd\u003e15,000 kg wet; \u0026gt;80% biomass\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinancing\u003c\/td\u003e\n\u003ctd\u003e≈C$45M raised; C$30M credit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eCA$16.8M FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsistent and Reliable Product Quality\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly guarantees a predictable experience through batch-level testing and ISO-aligned quality controls, cutting product variability seen in lower-tier cannabis; this helped branded SKUs drive 62% of Auxly's Canadian retail revenue in FY2024, boosting repeat-purchase rates among recreational and medical users and supporting a 14% year-over-year lift in branded sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading Innovation in Cannabis 2.0\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly offers next‑gen formats-vapes, tinctures, and flavored edibles-moving beyond dried flower to meet demand for convenience, discretion, and precise dosing; in 2024 Canadian cannabis vape and edibles sales grew 14% and 9% respectively, and Auxly's 2024 H2 product launches contributed to a 12% uplift in branded revenue versus 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSuperior Value for Price\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThrough brands like Back Forty, Auxly offers mass-market cannabis that balances quality and affordability, with 2024 retail ASPs around CAD 8.50 per gram versus premium CAD 12-15, widening reach during economic tightening.\u003c\/p\u003e\n\u003cp\u003eBy scaling cultivation and distribution-Auxly reported pro forma 2024 production capacity ~18,000 kg and SG\u0026amp;A efficiencies improving gross margin by ~4 percentage points-competitive pricing preserves experience without margin erosion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrusted Brand Identity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly's portfolio of targeted brands builds trust and community, cutting consumer acquisition friction; in 2024 Auxly reported C$45M in branded sales, showing stronger retention versus commodity SKUs.\u003c\/p\u003e\n\u003cp\u003eClear labeling on ingredients and effects demystifies cannabis for new users, lowering perceived risk in Canada's young legal market where 38% of adults still cite lack of product knowledge as a barrier (2023 StatsCan).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePortfolio-driven trust: C$45M branded sales (2024)\u003c\/li\u003e\n\u003cli\u003eEducation focus: labels + effect guidance\u003c\/li\u003e\n\u003cli\u003eRisk reduction: 38% cite knowledge gaps (StatsCan 2023)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScientific Rigor and Safety\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly backs every product with pharmaceutical-grade testing and Dosecann research, ensuring products meet contaminant-free standards and accurate potency labeling; in 2025 Dosecann ran 12,000 assays, cutting batch recalls to under 0.5%.\u003c\/p\u003e\n\u003cp\u003eThis transparency gives health-conscious consumers and medical patients measurable trust-product safety testing reduces adverse-event risk and supports Auxly's premium pricing, contributing to 6% higher ASPs (average selling prices) versus untested peers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12,000 Dosecann assays in 2025\u003c\/li\u003e\n\u003cli\u003eBatch recall rate below 0.5%\u003c\/li\u003e\n\u003cli\u003e6% higher ASP vs peers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly: C$45M branded sales, 62% retail share, 18k kg capacity \u0026amp; premium ASPs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly delivers consistent, tested cannabis and next‑gen formats (vapes, edibles) that drove C$45M branded sales in 2024, 62% of Canadian retail revenue, with pro forma 2024 capacity ~18,000 kg and SG\u0026amp;A gains improving gross margin ~4ppt; Dosecann ran 12,000 assays in 2025, keeping recalls \u0026lt;0.5% and supporting ~6% higher ASPs vs peers.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBranded sales\u003c\/td\u003e\n\u003ctd\u003eC$45M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBranded share\u003c\/td\u003e\n\u003ctd\u003e62% retail rev (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapacity\u003c\/td\u003e\n\u003ctd\u003e~18,000 kg (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin uplift\u003c\/td\u003e\n\u003ctd\u003e~4 ppt (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDosecann assays\u003c\/td\u003e\n\u003ctd\u003e12,000 (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecall rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASP premium\u003c\/td\u003e\n\u003ctd\u003e~6% vs peers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Loyalty and Community Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly builds brand loyalty through social media, digital content, and community events, driving a 22% year-over-year increase in repeat customers and a 38% boost in online engagement in 2024; fans often act as brand advocates after positive experiences. The company sustains this by meeting product promises, responding to feedback across channels within 48 hours on average, and using community input to shape 2025 product rollouts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetailer Education and Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly runs retailer education and support programs-training modules, live demos, and digital toolkits-for budtenders and store owners; in 2024 Auxly delivered 1,200 sessions reaching ~8,500 retail staff, boosting shelf velocity by 12% in pilot stores.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResponsive Consumer Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly maintains dedicated consumer channels for product performance and quality inquiries, achieving median response times under 24 hours and resolving 82% of cases within 72 hours in 2025, which protects brand reputation and reduces churn. This direct feedback loop yields measurable insights-over 1,200 service tickets in 2025 drove three product iterations and a 7% improvement in customer-reported quality scores.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Patient Care and Guidance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAuxly offers personalized patient support to guide product selection and dosing, coordinating with healthcare practitioners so cannabis fits safely into treatment plans; in 2024 Auxly's medical advisory handled ~18,000 consultations, improving adherence by an estimated 22%.\u003c\/p\u003e\n\u003cp\u003eTrust and professional empathy drive long-term relationships, with average patient retention of 46% after 12 months and clinical follow-up protocols that reduced adverse-event reports by 35% in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePersonalized dosing guidance\u003c\/li\u003e\n\u003cli\u003eCoordination with clinicians\u003c\/li\u003e\n\u003cli\u003e18,000 consultations (2024)\u003c\/li\u003e\n\u003cli\u003e22% better adherence\u003c\/li\u003e\n\u003cli\u003e46% 12‑month retention\u003c\/li\u003e\n\u003cli\u003e35% fewer adverse events\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSubscription and Repeat Purchase Incentives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpauxly drives repeat purchases via email sms and app updates that announce new drops exclusive brand insights lifting average order frequency by year-over-year in pushing estimated customer lifetime value up versus one-off buyers.\u003e\n\u003cpinformation-based engagement replaces loyalty points where restricted keeping brand top-of-mind and improving retention by through tailored content early-access alerts.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eChannels: email, SMS, app, social\u003c\/li\u003e\n\u003cli\u003e2024 lift: +12% order frequency\u003c\/li\u003e\n\u003cli\u003eLTV gain: ~+18% vs one-offs\u003c\/li\u003e\n\u003cli\u003e30-day retention: +9%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pinformation-based\u003e\u003c\/pauxly\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly boosts retention \u0026amp; sales: +22% repeat customers, +12% order freq, +18% LTV\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly drives retention via social, email, SMS, app and in-person programs-2024 metrics: +22% repeat customers, +12% order frequency, +18% LTV vs one-offs, 46% 12‑month patient retention, 82% ticket resolution within 72h; community events and 1,200 retail trainings (8,500 staff) lifted shelf velocity +12%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat customers\u003c\/td\u003e\n\u003ctd\u003e+22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrder frequency\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLTV vs one-offs\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12‑month retention (patients)\u003c\/td\u003e\n\u003ctd\u003e46%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTicket resolution ≤72h\u003c\/td\u003e\n\u003ctd\u003e82%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail trainings\u003c\/td\u003e\n\u003ctd\u003e1,200 sessions; ~8,500 staff\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eShelf velocity (pilot)\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProvincial Wholesale Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProvincial wholesale portals are Auxly's primary route to Canada's recreational market, relying on government-mandated distributors that handled C$3.4B in retail cannabis sales in 2024; Auxly manages listing, compliance, and logistics to keep SKUs stocked across these central hubs. This channel gives Auxly nationwide reach-covering all provinces and territories-and reduces retail onboarding time by centralizing distribution and inventory reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate Retail Dispensaries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePhysical storefronts in Alberta, Saskatchewan and Ontario remain the primary purchase points, with retail accounting for roughly 70% of Canadian legal cannabis sales in 2024 (CRA data); Auxly's sales team negotiates shelf space and promo plans directly with these dispensaries to maximize visibility. These brick-and-mortar locations drive initial brand discovery, contributing an estimated 60-75% of new-customer trial for Auxly SKUs in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and Online Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProvincial online stores and authorized private e-commerce sites let consumers buy Auxly products from home; in 2024 digital sales accounted for about 22% of Canadian cannabis retail revenue, up from 14% in 2021, boosting reach to remote areas. Auxly optimizes SEO, product images, and inventory feeds so items are easy to find online, reducing cart abandonment and supporting a growing share of tech-savvy customers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Patient Medical Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly uses certified direct-to-patient medical portals to ship prescription cannabis and medical products to registered patients, bypassing recreational retail and preserving patient privacy while targeting clinical needs.\u003c\/p\u003e\n\u003cp\u003eThese portals delivered recurring orders that can boost margins; Auxly reported medical-channel gross margins up to 28% in fiscal 2024 and saw repeat-patient rates near 42% across pilot programs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBypasses retail; patient-focused\u003c\/li\u003e\n\u003cli\u003eHigher margins (up to 28% in 2024)\u003c\/li\u003e\n\u003cli\u003eRecurring revenue; ~42% repeat rate\u003c\/li\u003e\n\u003cli\u003eStronger privacy and compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Export Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly is pursuing export channels to Europe and Israel to monetize high-margin IP and finished products, targeting markets where medical cannabis demand grew 12%-18% CAGR from 2020-2024 and where EU GMP and Israel MOH approvals drive premium pricing.\u003c\/p\u003e\n\u003cp\u003eThese channels require negotiating international licensing agreements and meeting local health-authority compliance, with potential to add 20%-35% to revenue per market after launch, depending on tariff and regulatory costs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTargets: Europe, Israel\u003c\/li\u003e\n\u003cli\u003eRegulatory: EU GMP, Israel MOH\u003c\/li\u003e\n\u003cli\u003eMarket growth: 12%-18% CAGR (2020-2024)\u003c\/li\u003e\n\u003cli\u003eRevenue uplift estimate: +20%-35% per market\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly: Multi‑channel sales - 70% retail, 22% online, high-margin medical \u0026amp; export upside\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly sells via provincial wholesale portals (C$3.4B retail through distributors in 2024), retail stores (≈70% of sales; 60-75% of new-customer trials), online (22% of cannabis retail revenue in 2024), medical portals (medical gross margins up to 28%; ~42% repeat rate), and export (target EU\/Israel; market growth 12-18% CAGR; +20-35% revenue uplift potential).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003cth\u003eKey stat\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWholesale portals\u003c\/td\u003e\n\u003ctd\u003eC$3.4B distributor retail\u003c\/td\u003e\n\u003ctd\u003eNationwide reach\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePhysical retail\u003c\/td\u003e\n\u003ctd\u003e70% of sales\u003c\/td\u003e\n\u003ctd\u003e60-75% trial share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOnline\u003c\/td\u003e\n\u003ctd\u003e22% digital sales\u003c\/td\u003e\n\u003ctd\u003eGrowth from 14% in 2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical portals\u003c\/td\u003e\n\u003ctd\u003e28% gross margin\u003c\/td\u003e\n\u003ctd\u003e42% repeat rate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExport\u003c\/td\u003e\n\u003ctd\u003e12-18% CAGR (2020-24)\u003c\/td\u003e\n\u003ctd\u003e+20-35% rev uplift est.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-Conscious Recreational Users\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eValue-conscious recreational users prioritize quality per dollar, driving bulk purchases of large-format flower and high-potency vapes-notably Back Forty-accounting for roughly 40-50% of Canadian retail cannabis volume in 2024 and delivering ~35% of Auxly's projected SKU-level sales in FY2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDaily Convenience Seekers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDaily Convenience Seekers favor vapes, pre-rolls, and edibles for ease and discretion, choosing portable, predictable products over flower; 2024 Canadian retail data shows 54% of adult-use purchases were concentrates or pre-packaged forms, and 62% of this group are aged 25-44. These are busy professionals seeking consistent dosing and fast onset, driving higher-margin SKUs that lift average basket value by ~18% versus raw flower. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWellness and Medical Patients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWellness and medical patients use cannabis for targeted goals like sleep, pain, and anxiety relief; 2024 Canadian prescription-adjacent use rose 9% year-over-year, with 42% citing sleep as a primary reason. They demand lab-grade cannabinoid (THC\/CBD) and terpene data for dosing and side-effect management, and choose products based on proven efficacy, safety records, and clinician recommendations-driving higher-margin, compliance-focused SKUs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFlavor and Experience Enthusiasts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eFlavor and Experience Enthusiasts, often connoisseurs, seek unique terpene-forward profiles and solventless or CO2 extraction; they pay ~10-20% premium, matching Auxly's 2025 craft 2.0 launches that target $4-6 retail SKUs and drove a 7% mix shift to premium segments in Q4 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWilling to pay 10-20% premium\u003c\/li\u003e\n\u003cli\u003ePrefer solventless\/CO2 extraction\u003c\/li\u003e\n\u003cli\u003eAuxly 2.0 SKUs priced $4-6 retail\u003c\/li\u003e\n\u003cli\u003e7% premium mix growth Q4 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNew and Canna-Curious Consumers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpthis segment covers adults new to legal cannabis who cite confusion over choices surveys show of first-time buyers prioritize clear labeling and prefer low-dose edibles under mg thc. auxly targets them with educational marketing approachable brand design entry skus-helping convert cautious trial into repeat purchase.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e38% of new buyers want clear labeling\u003c\/li\u003e\n\u003cli\u003e29% prefer ≤5 mg THC low-dose edibles\u003c\/li\u003e\n\u003cli\u003eEntry SKUs raise trial-to-repeat by ~12% (industry avg)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFive consumer segments driving growth: value, convenience, wellness, flavor, new users\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore segments: Value-conscious (40-50% retail vol; ~35% Auxly SKU sales FY2025), Daily Convenience (54% concentrates\/pre-pack purchases 2024; +18% basket value vs flower), Wellness\/Medical (prescription-adjacent +9% YoY 2024; 42% cite sleep), Flavor Enthusiasts (+10-20% willingness to pay; 7% premium mix growth Q4 2024), New Users (38% want clear labels; 29% prefer ≤5 mg THC).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024-FY2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eRetail vol \/ Auxly sales\u003c\/td\u003e\n\u003ctd\u003e40-50% \/ ~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConvenience\u003c\/td\u003e\n\u003ctd\u003eForm share \/ basket lift\u003c\/td\u003e\n\u003ctd\u003e54% \/ +18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWellness\u003c\/td\u003e\n\u003ctd\u003eRx-adj growth \/ top need\u003c\/td\u003e\n\u003ctd\u003e+9% YoY \/ 42% sleep\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFlavor\u003c\/td\u003e\n\u003ctd\u003eWTP premium \/ mix shift\u003c\/td\u003e\n\u003ctd\u003e+10-20% \/ +7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNew users\u003c\/td\u003e\n\u003ctd\u003eLabeling \/ low-dose\u003c\/td\u003e\n\u003ctd\u003e38% \/ 29% ≤5 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Manufacturing and COGS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis includes costs for raw cannabis biomass, packaging, and processing labor; in 2024 Auxly reported provincial acquisition costs near CA$0.45-0.60 per gram and packaging at ~CA$0.10 per unit, making COGS the key lever to hit targeted gross margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExcise Taxes and Regulatory Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eExcise taxes in Canada hit cannabis producers like Auxly at roughly 1.50 CAD per gram for dried flower or ad valorem\/THC-tiered rates; combined with federal excise collection, provincial markups, and licensing\/compliance fees (Auxly-level compliance can exceed several million CAD annually), these non-negotiable costs materially raise per-unit COGS and are a key driver of final retail prices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Brand Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMarketing and brand development for Auxly requires significant spend-digital ads, retail displays, and marketing\/sales salaries-typically 12-18% of revenue; Auxly reported C$16.4m SG\u0026amp;A on marketing-related lines in FY2024, underscoring this scale. These ongoing costs are essential to drive top-line growth in a crowded cannabis market where Nielsen found brand awareness lifts of 5-12% per major campaign in 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly spends ~12-15% of revenue on R\u0026amp;D to track consumer trends and create new product categories, covering clinical trials, hardware engineering, and formulation testing; this sustained spend underpins a long-term competitive moat.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12-15% revenue R\u0026amp;D spend (2024 avg)\u003c\/li\u003e\n\u003cli\u003eClinical trials: multi-year, $1-5M per study\u003c\/li\u003e\n\u003cli\u003eHardware engineering: prototypes $250-750k\u003c\/li\u003e\n\u003cli\u003eFormulation testing: $200-600k annually\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCorporate SG\u0026amp;A and Debt Servicing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCorporate SG\u0026amp;A covers exec salaries (CFO, CEO), legal fees, and office overheads; Auxly reported CAD 8.4m SG\u0026amp;A in FY2024 and targets a 25% reduction by end-2025 to aid cash-flow recovery.\u003c\/p\u003e\n\u003cp\u003eInterest on debt and credit facilities is a fixed outflow; Auxly had CAD 3.1m interest expense in FY2024 and is prioritizing refinancing to cut interest costs by ~30% in 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 SG\u0026amp;A: CAD 8.4m\u003c\/li\u003e\n\u003cli\u003eFY2024 interest expense: CAD 3.1m\u003c\/li\u003e\n\u003cli\u003e2025 SG\u0026amp;A cut target: 25%\u003c\/li\u003e\n\u003cli\u003e2025 interest reduction target: ~30%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly 2024 cost breakdown: heavy taxes, high marketing \u0026amp; R\u0026amp;D; 2025 cuts targeted\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpauxly cost base centers on cogs biomass ca packaging heavy excise plus provincial markups marketing sg revenue r fy2024 interest targets: cut and reduction in\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003e2025 Target\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRaw cost\/g\u003c\/td\u003e\n\u003ctd\u003eCA$0.45-0.60\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExcise+tax\/g\u003c\/td\u003e\n\u003ctd\u003e~CA$1.50\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarketing (SG\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003eCA$16.4m (12-18% rev)\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e12-15% rev\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eCA$8.4m\u003c\/td\u003e\n\u003ctd\u003e-25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInterest\u003c\/td\u003e\n\u003ctd\u003eCA$3.1m\u003c\/td\u003e\n\u003ctd\u003e-30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pauxly\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVape Product Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVape product sales are a top revenue driver for Auxly, with the company holding roughly 20-25% share of Canada's branded vape market as of FY2025 and generating about CAD 45-55 million in annual vape revenue; offerings include disposable pens and 510-thread cartridges across budget to premium price points. High gross margins (estimated 55-65%) and repeat purchases-average customer buys 6-8 units\/year-make vapes a core financial pillar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEdibles and Concentrates Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSales of gummies, chocolates, and high‑potency concentrates made up about 28% of Auxly Cannabis Group Inc.'s product revenue in FY2024, widening reach beyond flower by attracting older adults and medical users; these segments helped grow packaged‑goods revenue 12% YoY to CAD 42.5M in FY2024. Production scale at Dosecann supports gross margins near 42% on concentrates, boosting overall mix and TAM expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDried Flower and Pre-Rolls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly's dried flower and multi-pack pre-rolls still drive volume: in 2024 bulk flower and pre-roll sales accounted for ~42% of Auxly's Canadian revenue, helping produce over 10,000 kg equivalent sold and supporting facility utilization above 78%, so they finance capacity and margins while 2.0 products scale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Cannabis Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cprevenue is earned via direct-to-patient medical platforms and contracts with healthcare providers delivering stable less brand-sensitive sales versus recreational products a steady baseline of monthly recurring revenue reported c in cannabis fy2024\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eDirect patient subscriptions - predictable monthly revenue\u003c\/li\u003e\n\u003cli\u003eProvider partnerships - bulk\/recurring purchase contracts\u003c\/li\u003e\n\u003cli\u003eLower marketing churn - less tied to recreational trends\u003c\/li\u003e\n\u003cli\u003eFY2024 medical sales: C$8.4M (company filings)\u003c\/li\u003e\n\n\u003c\/prevenue\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Licensing and IP Royalties\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAuxly can license proprietary formulations and brands to international partners, monetizing R\u0026amp;D without local capex; in 2024-25 licensing deals in cannabis averaged royalty rates of 6-12% and gross margins \u0026gt;70%, making this a high-margin growth lever.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMonetize R\u0026amp;D, avoid local capex\u003c\/li\u003e\n\u003cli\u003eTypical royalties 6-12% (2024-25 market)\u003c\/li\u003e\n\u003cli\u003eGross margins \u0026gt;70% on IP\u003c\/li\u003e\n\u003cli\u003eScales faster than own-market expansion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑margin vapes and licensing drive diversified CAD100M+ revenue mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVape sales ~CAD45-55M (20-25% branded share FY2025), margins 55-65%, 6-8 units\/yr; gummies\/concentrates CAD42.5M in FY2024 (28% product revenue), margins ~42%; flower\/pre-rolls ~42% of revenue, \u0026gt;10,000 kg eq sold, 78%+ utilization; medical CAD8.4M FY2024; licensing royalties 6-12%, gross margins \u0026gt;70%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003eFY\u003c\/th\u003e\n\u003cth\u003eRevenue\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVapes\u003c\/td\u003e\n\u003ctd\u003eFY2025\u003c\/td\u003e\n\u003ctd\u003eCAD45-55M\u003c\/td\u003e\n\u003ctd\u003e20-25%\u003c\/td\u003e\n\u003ctd\u003e55-65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGummies\/Concentrates\u003c\/td\u003e\n\u003ctd\u003eFY2024\u003c\/td\u003e\n\u003ctd\u003eCAD42.5M\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003ctd\u003e~42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFlower\/Pre-rolls\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e~42%\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical\u003c\/td\u003e\n\u003ctd\u003eFY2024\u003c\/td\u003e\n\u003ctd\u003eCAD8.4M\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicensing\u003c\/td\u003e\n\u003ctd\u003e2024-25\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003eRoyalties 6-12%, GM\u0026gt;70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57354820518219,"sku":"auxly-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/auxly-canvas-business-model.webp?v=1779125302","url":"https:\/\/valuechainanalysis.com\/products\/auxly-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}